Norinchukin Bank’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.88M Buy
90,805
+376
+0.4% +$20.4K 0.04% 235
2026
Q1
$5.67M Buy
90,429
+304
+0.3% +$24.3K 0.07% 161
2025
Q4
$8.59M Buy
90,125
+5,748
+7% +$564K 0.1% 121
2025
Q3
$8.24M Buy
84,377
+1,540
+2% +$159K 0.11% 119
2025
Q2
$8.9M Buy
82,837
+6,911
+9% +$699K 0.13% 109
2025
Q1
$7.66M Buy
75,926
+9,955
+15% +$1M 0.14% 102
2024
Q4
$5.89M Buy
65,971
+5,484
+9% +$483K 0.12% 106
2024
Q3
$5.07M Buy
60,487
+8,508
+16% +$671K 0.12% 114
2024
Q2
$4M Buy
51,979
+1,323
+3% +$96.8K 0.11% 111
2024
Q1
$3.47M Sell
50,656
-676
-1% -$43.5K 0.1% 131
2023
Q4
$2.97M Sell
51,332
-4,870
-9% -$260K 0.07% 138
2023
Q3
$2.97M Sell
56,202
-60,194
-52% -$3.16M 0.07% 143
2023
Q2
$6.3M Buy
116,396
+24,850
+27% +$1.3M 0.11% 135
2023
Q1
$4.58M Buy
91,546
+2,788
+3% +$131K 0.09% 133
2022
Q4
$4.11M Sell
88,758
-20,899
-19% -$905K 0.09% 142
2022
Q3
$4.25M Buy
109,657
+12,297
+13% +$493K 0.09% 146
2022
Q2
$3.63M Sell
97,360
-34,851
-26% -$1.42M 0.07% 159
2022
Q1
$5.86M Buy
132,211
+10,089
+8% +$437K 0.08% 150
2021
Q4
$5.19M Sell
122,122
-679
-0.6% -$28.5K 0.07% 157
2021
Q3
$5.33M Buy
122,801
+5,230
+4% +$231K 0.07% 141
2021
Q2
$5.03M Sell
117,571
-305
-0.3% -$12.8K 0.07% 142
2021
Q1
$4.56M Buy
117,876
+683
+0.6% +$25.9K 0.06% 144
2020
Q4
$4.21M Sell
117,193
-2,828
-2% -$102K 0.06% 142
2020
Q3
$4.59M Buy
120,021
+1,699
+1% +$65.5K 0.07% 127
2020
Q2
$4.15M Buy
118,322
+1,682
+1% +$60.6K 0.07% 132
2020
Q1
$3.81M Sell
116,640
-67,921
-37% -$2.65M 0.07% 127
2019
Q4
$8.35M Sell
184,561
-16,757
-8% -$701K 0.11% 118
2019
Q3
$8.19M Buy
201,318
+5,271
+3% +$223K 0.12% 125
2019
Q2
$8.43M Sell
196,047
-67,005
-25% -$2.58M 0.13% 110
2019
Q1
$10.1M Buy
263,052
+9,556
+4% +$365K 0.13% 124
2018
Q4
$8.96M Buy
253,496
+75,624
+43% +$2.74M 0.13% 124
2018
Q3
$6.85M Buy
177,872
+21,539
+14% +$752K 0.09% 129
2018
Q2
$5.11M Buy
156,333
+30,349
+24% +$915K 0.08% 138
2018
Q1
$3.44M Buy
125,984
+16,194
+15% +$440K 0.06% 156
2017
Q4
$2.72M Buy
109,790
+7,662
+8% +$211K 0.05% 185
2017
Q3
$2.98M Buy
102,128
+7,097
+7% +$196K 0.06% 179
2017
Q2
$2.63M Buy
95,031
+6,428
+7% +$171K 0.05% 188
2017
Q1
$2.2M Buy
88,603
+5,999
+7% +$146K 0.05% 213
2016
Q4
$1.79M Buy
82,604
+9,752
+13% +$213K 0.04% 235
2016
Q3
$1.73M Buy
72,852
+1,683
+2% +$40.1K 0.04% 230
2016
Q2
$1.66M Buy
71,169
+1,972
+3% +$42.7K 0.04% 229
2016
Q1
$1.3M Buy
69,197
+6,350
+10% +$112K 0.03% 264
2015
Q4
$1.16M Sell
62,847
-14,044
-18% -$252K 0.03% 269
2015
Q3
$1.26M Buy
76,891
+993
+1% +$17K 0.03% 276
2015
Q2
$1.34M Sell
75,898
-2,985
-4% -$53.3K 0.03% 279
2015
Q1
$1.4M Buy
78,883
+721
+0.9% +$11.4K 0.03% 276
2014
Q4
$1.04M Buy
78,162
+24,936
+47% +$319K 0.03% 324
2014
Q3
$629K Buy
53,226
+3,869
+8% +$48.7K 0.02% 290
2014
Q2
$630K Sell
49,357
-5,437
-10% -$70.7K 0.02% 256
2014
Q1
$741K Buy
54,794
+4,919
+10% +$64.6K 0.02% 241
2013
Q4
$599K Sell
49,875
-561
-1% -$6.63K 0.02% 266
2013
Q3
$592K Buy
50,436
+3,711
+8% +$40.1K 0.02% 249
2013
Q2
$433K Buy
+46,725
New +$396K 0.01% 281

Other funds holding BSX

Norinchukin Bank's BSX Position: Q2 2026 in Review

Norinchukin Bank increased its Boston Scientific (BSX) stake by 0.42% in Q2 2026, buying an estimated $20.4K and bringing the position to 90,805 shares worth $3.88M. The position accounts for 0.04% of the portfolio, ranked #235.

Norinchukin Bank first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. The position peaked at $10.1M in Q1 2019. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Norinchukin Bank held 90,805 shares of Boston Scientific worth $3.88M as of Q2 2026.
  • Norinchukin Bank bought 376 Boston Scientific shares in Q2 2026, an estimated $20.4K.
  • Boston Scientific made up 0.04% of Norinchukin Bank's portfolio in Q2 2026, its #235 holding.
  • Norinchukin Bank first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
  • Norinchukin Bank's Boston Scientific position peaked at $10.1M in Q1 2019.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Norinchukin Bank's 13F filing for Q2 2026, filed 14 Aug 2026.